CALABRETTA, Bruno
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 18.903
EU - Europa 7.223
AS - Asia 1.729
Continente sconosciuto - Info sul continente non disponibili 29
OC - Oceania 8
SA - Sud America 8
AF - Africa 4
Totale 27.904
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 18.866
GB - Regno Unito 3.475
SE - Svezia 1.027
CN - Cina 755
UA - Ucraina 657
IT - Italia 624
DE - Germania 580
HK - Hong Kong 482
TR - Turchia 398
FI - Finlandia 351
BG - Bulgaria 258
FR - Francia 104
IE - Irlanda 35
BE - Belgio 33
CA - Canada 32
IN - India 31
NL - Olanda 26
RU - Federazione Russa 26
EU - Europa 25
IR - Iran 16
MY - Malesia 12
VN - Vietnam 10
SG - Singapore 9
JP - Giappone 8
AU - Australia 6
PL - Polonia 5
A2 - ???statistics.table.value.countryCode.A2??? 4
BR - Brasile 4
CH - Svizzera 4
AT - Austria 3
BZ - Belize 3
KR - Corea 3
CZ - Repubblica Ceca 2
ES - Italia 2
GR - Grecia 2
HR - Croazia 2
NZ - Nuova Zelanda 2
PE - Perù 2
SI - Slovenia 2
AE - Emirati Arabi Uniti 1
BT - Bhutan 1
CL - Cile 1
CO - Colombia 1
DK - Danimarca 1
GH - Ghana 1
HU - Ungheria 1
IL - Israele 1
LK - Sri Lanka 1
LV - Lettonia 1
MA - Marocco 1
MD - Moldavia 1
MO - Macao, regione amministrativa speciale della Cina 1
MX - Messico 1
RO - Romania 1
SC - Seychelles 1
TT - Trinidad e Tobago 1
ZA - Sudafrica 1
Totale 27.904
Salva come PNG Salva come JPEG
Città #
Southend 3.067
Fairfield 2.810
Woodbridge 2.275
Houston 1.607
Jacksonville 1.534
Ashburn 1.194
Ann Arbor 1.133
Chandler 1.095
Cambridge 1.000
Wilmington 996
Seattle 993
Dearborn 902
Nyköping 746
Hong Kong 478
Modena 421
San Diego 331
Beijing 287
Princeton 270
Sofia 257
Eugene 250
Izmir 210
Des Moines 122
Helsinki 114
New York 104
Redwood City 102
London 95
Falls Church 82
Norwalk 52
Boardman 46
Shanghai 41
Nanjing 37
Dublin 35
Hefei 34
Brussels 33
Bremen 27
Hounslow 26
Milan 26
Toronto 25
Kilburn 24
Fremont 21
Dongguan 20
Kunming 20
Philadelphia 20
Saint Petersburg 20
Chiswick 16
Verona 16
Chicago 14
Indiana 14
San Mateo 14
Guangzhou 12
Mountain View 12
Grafing 11
Phoenix 11
Prescot 11
San Jose 10
Jinan 9
Monmouth Junction 9
Rome 9
Ardabil 8
Auburn Hills 8
Dong Ket 8
Dronten 8
Shenyang 8
Washington 8
Fuzhou 7
Groningen 7
Nanchang 7
Zhengzhou 7
Augusta 6
Islington 6
Parma 6
Hanover 5
Ottawa 5
Chongqing 4
Kraków 4
Lausanne 4
Leawood 4
Los Angeles 4
Occhiobello 4
Pune 4
Quzhou 4
Redmond 4
San Francisco 4
San Giuliano Milanese 4
Torino 4
Wandsworth 4
Wuhan 4
Albuquerque 3
Andria 3
Atlanta 3
Bangalore 3
Belize City 3
Chengdu 3
Fort Worth 3
Hebei 3
Naples 3
New Bedfont 3
Paris 3
Reggio Nell'emilia 3
Southwark 3
Totale 23.349
Salva come PNG Salva come JPEG
Nome #
KLF4 mediates the effect of 5-ASA on the b-catenin pathway in colon cancer cells 286
ATG7 regulates energy metabolism, differentiation and survival of Philadelphia-chromosome-positive cells 239
Elongation factor 1 alpha interacts with phospho-Akt in breast cancer cells and regulates their proliferation, survival and motility 227
Monocyte-macrophage differentiation of acute myeloid leukemia cell lines by small molecules identified through interrogation of the Connectivity Map database 224
Expression of μ-protocadherin is negatively regulated by the activation of the β-catenin signaling pathway in normal and cancer colorectal enterocytes 223
Suppression of invasion and metastasis of triple-negative breast cancer lines by pharmacological or genetic inhibition of slug activity 196
BCR-ABL antisense oligodeoxynucleotide in vitro purging and autologous bone marrow transplantation for patients with chronic myelogenous leukemia in advanced phase. 194
Requirement of c-Myb for p210(BCR/ABL)-dependent transformation of hematopoietic progenitors and leukemogenesis 190
c-Myb and its target Bmi1 are required for p190BCR/ABL leukemogenesis in mouse and human cells 183
CDKN2A-independent role of BMI1 in promoting growth and survival of Ph+ acute lymphoblastic leukemia 172
Phosphorylation of serine 21 modulates the proliferation inhibitory more than the differentiation inducing effects of C/EBPα in K562 cells. 170
Enhanced proliferative potential of hematopoietic cells expressing degradation-resistant c-Myb mutants 169
Expression of p89(c-Mybex9b), an alternatively spliced form of c-Myb, is required for proliferation and survival of p210BCR/ABL-expressing cells. 169
Regulation of Balb/c3T3 fibroblast proliferation by B-myb is accompanied by selective activation of cdc2 and cyclin D1 expression. 167
A degradation-resistant c-Myb mutant cooperates with Bcl-2 in enhancing proliferative potential and survival of hematopoietic cells 163
BCR-ABL prevents c-Jun-mediated and proteasome-dependent FUS (TLS) proteolysis through a protein kinase C beta II-dependent pathway 163
Effects of C/EBP alpha and C/EBP beta in BCR/ABL-expressing cells - Differences and similarities 162
Altered expression of G1 specific genes in human malignant myeloid cells. 160
Different frequency classes of sequences in heterogeneous nuclear RNA of normal promyelocytes and lymphoblasts and of leukemic blast cells of circulating blood and of the HL60 line. 159
Positive autoregulation of c-myb expression via myb binding sites in the 5' flanking region of the human c-myb gene 157
Suppression of autophagy by BCR/ABL 156
The p53 Codon 72 Pro/Pro Genotype Identifies Poor-Prognosis Neuroblastoma Patients: Correlation with Reduced Apoptosis and Enhanced Senescence by the p53-72P Isoform. 156
Impact of a single nucleotide polymorphism in the MDM2 gene on neuroblastoma development and aggressiveness: results of a pilot study on 239 patients 155
Gfi-1 inhibits proliferation and colony formation of p210BCR/ABL-expressing cells viatranscriptional repression of STAT 5 and Mcl-1 155
Inhibiting interactions of lysine demethylase LSD1 with Snail/Slug blocks cancer cell invasion. 155
Activation of human B-MYB by cyclins. 154
The SH3 domain contributes to BCR/ABL-dependent leukemogenesis in vivo: role in adhesion, invasion, and homing. 153
Inhibition of autophagy: a new strategy to enhance sensitivity of chronic myeloid leukemia stem cells to tyrosine kinase inhibitors 153
Structure-based screen identifies a potent small molecule inhibitor of Stat5a/b with therapeutic potential for prostate cancer and chronic myeloid leukemia 153
Delivery of c-myb antisense oligodeoxynucleotides to human neuroblastoma cells via disialoganglioside GD(2)-targeted immunoliposomes: antitumor effects 150
Regulation of microRNA-145 by growth arrest and differentiation. 150
TLS/FUS, a pro-oncogene involved in multiple chromosomal translocations, is a novel regulator of BCR/ABL-mediated leukemogenesis 149
Cell-cycle-dependent expression of human ornithine decarboxylase. 148
Coding sequence and intron-exon junctions of the c-myb gene are intact in the chronic phase and blast crisis stages of chronic myeloid leukemia patients 148
Expression of Slug Is Regulated by c-Myb and Is Required for Invasion and Bone Marrow Homing of Cancer Cells of Different Origin 148
Multiple signaling pathways of the insulin-like growth factor 1 receptor in protection from apoptosis. 147
Coding sequence and growth regulation of the human vimentin gene. 147
Isolation and functional assessment of common, polymorphic variants of the B-MYB proto-oncogene associated with a reduced cancer risk 146
Signal transducer and activator of transcription (STAT)5 activation by BCR/ABL is dependent on intact Src homology (SH)3 and SH2 domains of BCR/ABL and is required for leukemogenesis. 145
Resistance to apoptosis in CTLL-2 cells constitutively expressing c-Myb is associated with induction of bcl-2 expression and Myb-dependent regulation of bcl-2 promoter activity 144
The transcription factors c-myb and GATA-2 act independently in the regulation of normal hematopoiesis. 144
Versatility of BCR/ABL-expressing leukemic cells in circumventing pro-apoptotic BAD effects 143
Translational regulation by the p210 BCR/ABL oncoprotein 141
Wild-type p53 differentially affects tumorigenic and metastatic potential of murine metastatic cell variants. 141
Leukemia stem cells: Old concepts and new perspectives 141
Structure of Nascent Chromatin Is Essential for Hematopoietic Lineage Specification 141
The transcription activation function of C/EBPalpha is required for induction of granulocytic differentiation 139
Role of pescadillo and upstream binding factor in the proliferation and differentiation of murine myeloid cells 139
miRNA let-7c promotes granulocytic differentiation in acute myeloid leukemia. 139
The Jun family members, c-Jun and JunD, transactivate the human c-myb promoter via an Ap1-like element. 138
Ectopic expression of A-myb in transgenic mice causes follicular hyperplasia and enhanced B lymphocyte proliferation. 137
hnRNP A1 nucleocytoplasmic shuttling activity is required for normal myelopoiesis and BCR/ABL leukemogenesis 137
Guidelines for the use and interpretation of assays for monitoring autophagy. 137
Expression of constitutively active Raf-1 in the mitochondria restores antiapoptotic and leukemogenic potential of a transformation-deficient BCR/ABL mutant 136
Antisense oligonucleotides. 135
Tumorigenic conversion of p53 deficient colon epithelial cells by an activated Ki-ras gene 135
Altered mRNA translation: possible mechanism for CML disease progression. 134
Antileukemia effect of c-myc N3′→P5′ phosphoramidate antisense oligonucleotides in vivo 134
Physical interaction between CDK9 and B-MYB results in suppression of B-MYB gene autoregulation. 133
Oligonucleotide N3'-->P5' phosphoramidates as antisense agents. 133
Antisense myb inhibition of purified erythroid progenitors in development and differentiation is linked to cycling activity and expression of DNA polymerase alpha. 133
G1/S transition in normal human T-lymphocytes requires the nuclear protein encoded by c-myb. 132
Regulation of proliferation and cytokine expression of bone marrow fibroblasts: role of c-myb. 132
Inducible activation of CEBPB, a gene negatively regulated by BCR/ABL, inhibits proliferation and promotes differentiation of BICRABL-expressing cells 131
Presence of a highly repetitive and widely dispersed DNA sequence in the human genome. 130
A c-myb antisense oligodeoxynucleotide inhibits normal human hematopoiesis in vitro. 130
Activation of p53-dependent responses in tumor cells treated with a PARC-interacting peptide 130
Expression of the myeloperoxidase gene in acute and chronic myeloid leukemias: relationship to the expression of cell cycle-related genes. 130
Transcriptional repression of c-Myb and GATA-2 is involved in the biologic effects of C/EBPalpha in p210BCR/ABL-expressing cells 129
Gene regulatory mechanisms operative on hematopoietic cells: proliferation, differentiation, and neoplasia. 129
Induction of hematopoietic commitment and erythromyeloid differentiation in embryonal stem cells constitutively expressing c-myb. 128
B-myb promotes S phase and is a downstream target of the negative regulator p107 in human cells. 128
TGF-β-induced c-Myb affects the expression of EMT-associated genes and promotes invasion of ER+ breast cancer cells. 127
Role of the c-myb and c-abl protooncogenes in human hematopoiesis. 127
Transformation of hematopoietic cells by BCR/ABL requires activation of PI-3k/Akt dependent pathway. 127
Targeting autophagy potentiates tyrosine kinase inhibitor–induced cell death in Philadelphia chromosome–positive cells, including primary CML stem cells 127
B-myb alters the response to myeloid precurson cells to G-CSF 126
Leukemia treatment in severe combined immunodeficiency mice by antisense oligodeoxynucleotides targeting cooperating oncogenes. 126
Role of p53 in hematopoietic recovery after cytotoxic treatment. 126
Stage-related proliferative activity determines c-myb functional requirements during normal human hematopoiesis. 125
Ectopic expression of decorin protein core causes a generalized growth suppression in neoplastic cells of various histogenetic origin and requires endogenous p21, an inhibitor of cyclin-dependent kinases. 125
BCR/ABL activates mdm2 rnRNA translation via the La antigen 124
Slug (SNAI2) down-regulation by RNA interference facilitates apoptosis and inhibits invasive growth in neuroblastoma preclinical models 124
Expression of c-myc and induction of DNA synthesis by platelet-poor plasma in human diploid fibroblasts. 123
The RB-related gene Rb2/p130 in neuroblastoma differentiation and in B-myb promoter down-regulation. 122
Prospects for gene-directed therapy with antisense oligodeoxynucleotides. 122
Effect of interleukin-2 on the expression of cell cycle genes in human T lymphocytes. 122
Blastic transformation of p53-deficient bone marrow cells by p210bcr/abl tyrosine kinase. 122
Inhibition of leukaemia cell proliferation by folic acid-polylysine-mediated introduction of c-myb antisense oligodeoxynucleotides into HL-60 cells. 121
Direct transactivation of the anti-apoptotic gene Apolipoprotein J (Clusterin) by B-MYB. 120
HLA DR associated invariant chain is highly expressed in chronic lymphocytic leukemia. 120
Growth regulated expression of B-myb in fibroblasts and hematopoietic cells. 120
Enhanced anti-tumor effects with microencapsulated c-myc antisense oligonucleotide. 119
Cooperative action of germ-line mutations in decorin and p53 accelerates lymphoma tumorigenesis. 119
BCR/ABL Regulation of PI-3 Kinase Activity 119
Selective inhibition of leukemia cell proliferation by bcr-abl antisense oligodeoxynucleotides. 119
Regulation of the expression of the hematopoietic stem cell antigen CD34: role of c-myb. 119
Cyclin D1-dependent regulation of B-myb activity in early stages of neuroblastoma differentiation. 119
The nucleoside diphosphate kinase activity of DRnm23 is not required for inhibition of differentiation and induction of apoptosis in 32Dcl3 myeloid precursor cells 118
Expression of CCL9/MIP-1γ is repressed by BCR/ABL and its restoration suppresses in vivo leukemogenesis of 32D-BCR/ABL cells 118
Totale 14.530
Salva come PNG Salva come JPEG
Categoria #
all - tutte 112.987
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 112.987
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20192.163 0 0 0 0 0 0 0 0 0 322 838 1.003
2019/20206.013 462 432 195 470 723 935 946 527 567 172 362 222
2020/20214.668 482 150 375 366 634 245 540 640 161 615 275 185
2021/20224.087 85 611 409 248 127 197 274 218 439 272 738 469
2022/20233.287 442 373 245 304 355 528 79 318 416 36 112 79
2023/20241.708 82 126 134 158 502 183 274 187 43 19 0 0
Totale 27.983